DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME9Z5R6

Market Closed - Bid/Ask 12:21:29 2024-07-05 EDT After market 15:43:57
8.6 EUR +0.23% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS 8.66 +0.70%
Current month-0.58%
1 month+26.36%
Date Price Change
24-07-05 8.6 +0.23%
24-07-03 8.58 -1.15%
24-07-02 8.68 +0.93%
24-07-01 8.6 -0.35%
24-06-28 8.63 +0.12%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 12:21 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9Z5R
ISINDE000ME9Z5R6
Date issued 2024-03-08
Strike 95 $
Maturity 2024-09-20 (77 Days)
Parity 1 : 1
Emission price 5.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.7
Lowest since issue 3.93
Spread 0.08
Spread %0.92%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.52 USD
Average target price
83.43 USD
Spread / Average Target
+45.05%
Consensus